Showing results (81-90 of 146) with videos related to

Sort By:
Pageof 15
Pharmaceuticals (Basel, Switzerland)|March 26, 2022
MiR-486-5p Targets CD133+ Lung Cancer Stem Cells through the p85/AKT PathwayMassimo Moro, Orazio Fortunato, Giulia Bertolini, et al.
Journal of Experimental & Clinical Cancer Research : CR|July 22, 2021
Circulating extracellular vesicles from individuals at high-risk of lung cancer induce pro-tumorigenic conversion of stromal cells through transfer of miR-126 and miR-320Francesca Pontis, Luca Roz, Mavis Mensah, et al.
BMC Cancer|September 20, 2018
Diagnostic role of circulating extracellular matrix-related proteins in non-small cell lung cancerFrancesca Andriani, Elena Landoni, Mavis Mensah, et al.
International Journal of Molecular Sciences|November 26, 2022
MiR-223 Exclusively Impairs In Vitro Tumor Growth through IGF1R Modulation in Rhabdomyosarcoma of Adolescents and Young AdultsMichela Casanova, Francesca Pontis, Patrizia Ghidotti, et al.
Scientific Reports|October 5, 2019
Toll-like receptor 3 as a new marker to detect high risk early stage Non-Small-Cell Lung Cancer patientsFrancesca Bianchi, Massimo Milione, Patrizia Casalini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 4, 2007
Radiation effects on development of HER2-positive breast carcinomasFabio Castiglioni, Monica Terenziani, Maria Luisa Carcangiu, et al.
Cancers|September 29, 2020
Beyond Traditional Morphological Characterization of Lung Neuroendocrine Neoplasms: In Silico Study of Next-Generation Sequencing Mutations Analysis across the Four World Health Organization Defined GroupsGiovanni Centonze, Davide Biganzoli, Natalie Prinzi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 15, 2014
Clinical utility of a plasma-based miRNA signature classifier within computed tomography lung cancer screening: a correlative MILD trial studyGabriella Sozzi, Mattia Boeri, Marta Rossi, et al.
Frontiers in Immunology|October 30, 2020
CXCR4 Inhibition Counteracts Immunosuppressive Properties of Metastatic NSCLC Stem CellsOrazio Fortunato, Dimas Carolina Belisario, Mara Compagno, et al.
The Lancet Regional Health. Europe|September 25, 2024
Blood microRNA testing in participants with suspicious low-dose CT findings: follow-up of the BioMILD lung cancer screening trialMattia Boeri, Federica Sabia, Roberta E Ledda, et al.
Pageof 15